Quince therapeutics to present at oppenheimer 34th annual healthcare life sciences conference

South san francisco, calif.--(business wire)---- $qncx--quince therapeutics, inc. (nasdaq: qncx), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient's own biology to deliver rare disease therapeutics, today announced that dirk thye, m.d., quince's chief executive officer and chief medical officer, will present at the oppenheimer 34th annual healthcare life sciences conference, a virtual event, on wednesday, february 14, 2024 beginning at 10:40 a.
QNCX Ratings Summary
QNCX Quant Ranking